Work

Supplementary Figure Legend from Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations

Year: 2023

Type: supplementary-materials

Abstract: 1.EZH2 and MEK-ERK and PI3K/AKT signaling pathway expression in lung adenocarcinoma and HBEC cell lines and 2. Sensitivity in vitro to AZD6244 and MK2206 in combination with selective EZH2 inhibitor GSK343, EPZ6438 and GSK126 in NSCLC cells.

DOI: 10.1158/0008-5472.22409301.v1

Authors: Erick Riquelme, Carmen Behrens, Heather Y. Lin, George Simon, Vassiliki Papadimitrakopoulou, Julie Izzo, Cesar Moran, Neda Kalhor, J. Jack Lee, John D. Minna, Ignacio I. Wistuba

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361850485

Cites:

Cited by:

Related to: 10